Ravi Vyzasatya

Ravi Vyzasatya

Lonza Biologics - Visp / Switzerland
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 5400126
-
person_outline Ravi Vyzasatya's MOST POPULAR ARTICLES
1-) Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in miceA Jain, HS Olsen, R Vyzasatya, E Burch, Y Sakoda, EY Mérigeon, L Cai, ...Arthritis research & therapy 14, 1-12, 2012672012
2-) Evaluating the quality of a cell counting measurement process via a dilution series experimental designS Sarkar, SP Lund, R Vyzasatya, P Vanguri, JT Elliott, AL Plant, ...Cytotherapy 19 (12), 1509-1521, 2017272017
3-) Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancerA Jain, B Poonia, EC So, R Vyzasatya, EE Burch, HS Olsen, EY Mérigeon, ...European journal of cancer 49 (15), 3344-3352, 2013202013
4-) The Cre-loxP recombination-based reporter system for plant transcriptional expression studiesT Shigaki, RR Vyzasatya, AB Sivitz, JM Ward, H Sze, KD HirschiPlant molecular biology 58, 65-73, 2005112005
5-) 2014 TERMIS-AM ConferenceWashington, DCDecember 13–16, 2014L Wong, D Glaser, Y Choi, J Pegan, A Engler, J Sim, B Pruitt, M Khine, ...Tissue Engineering Part A 20 (S1), s-1-s-140, 201412014